GT719 Injection
GRIT-CD-CHN-719-001-056
Phase 2 mab active
Quick answer
GT719 Injection for Hematological Malignancy (Leukemia- Lymphoma) is a Phase 2 program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Hematological Malignancy (Leukemia- Lymphoma)
- Phase
- Phase 2
- Modality
- mab
- Status
- active